Submitted by admin on Fri, 2025-04-25 13:25

Ultomiris

  • Brand name/Generic name: Ultomiris/ravulizumab-cwvz
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: approximately 30 to 90 minutes depending on dose
  • Frequency of Treatment: varies based on dose
  • Conditions this Medication Treats:
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • atypical hemolytic uremic syndrome (aHUS)
    • generalized myasthenia gravis (gMG)
    • neuromyelitis optica spectrum disorder (NMOSD)
  • Link for more Information: https://ultomirishcp.com/
Main Image: